Oral hypeglycemic agents can have the following mechanism (s) of action: a. stimulating the pancreas to secrete more insulin b. increasing the sensitivity of insulin receptors in target tissues c. inhibiting the liver from producing glucose d. a and b e. all of the above If a patient receiving insulin should experience hypoglycemia, EARLY signs that might be noted include: a. weakness, sweating, shakiness, tremors, dixiness b. vomiting, increased respirations c. bradycardia, fatigue, and polydipsia d. nausea acetone breath, and coma e. none of the above The most common adverse effect of the oral hypoglycemic agents is: a. restlessness b. hyperglycemia c. hypoglycemia d. diaphoresis (profuse sweating) The most common adverse effect of insulin administration is: a. restlessness b. hyperglycemia c. hypoglycemia d. diaphoresis (profuse sweating) Some features of type 1 (IDDM) auto immune diabetes mellitus include: age of onset usually less than 20 years of age age of onset usually more than 35 years of age usually obese onset of symptoms is usually gradual onset of symptoms is usually sudden usually non-obese a. 1,4 , and 6 b. 1,5 , and 6 c. 2,3 , and 4 d. 2,3 , and 5
[Expert Solution]: Oral hypeglycemic agents can have the…
Need help with your General Clinical Pharmacology case study or NCLEX preparation? Connect with a verified Nursing expert now.